Healthtech Startups

Aradigm develops financial and delivery infrastructure for cell and gene therapies, partnering with payers, providers, manufacturers, and patients to enable sustainable access to transformative treatments through a pass-through business model.

2 investors

Aranda is a pharmaceutical company focused on developing and commercializing prescription and OTC products. The company leverages leadership experience in international pharmaceutical business development and product registration across European markets.

2 investors

Arata develops scientifically formulated haircare products focused on biological efficacy rather than trends. The company serves consumers seeking evidence-based hair and scalp care solutions.

2 investors

Araya (株式会社アラヤ) develops AI algorithms and products across deep learning, edge AI, and autonomous AI, and conducts research combining neuroscience and information theory, including work on consciousness in the brain and brain-machine interfaces. The Japanese company applies AI and brain science to industrial use cases.

2 investors

2 investors

ArcDia International develops and manufactures in vitro diagnostic solutions for acute infections such as COVID-19, influenza, RSV, and CDI, enabling rapid decentralized testing in hospitals, healthcare centers, and workplaces. The company also offers mariAST for antimicrobial susceptibility testing and mariCloud for real-time epidemiological surveillance.

2 investors

ArchForm provides clear aligner devices for orthodontic treatment, offering customers cost savings compared to alternative aligner companies.

2 investors

Arcomedlab develops personalized medicine implants and drug-releasing systems to improve patient quality of life. The company designs and manufactures medical devices including orthopedic and dental implants using advanced technologies such as 3D printing.

2 investors

Arc Therapeutics is a stealth-stage biopharmaceutical company developing medicines for central nervous system (CNS) conditions with high unmet medical needs.

2 investors

Arctx Medical develops an investigational cooling therapy device designed to treat acute pancreatitis by reducing pancreatic inflammation through localized temperature control. The company targets patients with acute inflammatory pancreatic disease to prevent progression to systemic illness and organ failure.

2 investors

Arcuro Medical develops all-suture soft-tissue repair technologies for orthopedic surgeons, with its flagship SuperBall® System providing knotless fixation for meniscal and rotator cuff procedures. The company serves sports medicine surgeons globally and holds FDA and CE regulatory clearances.

2 investors

Arena Labs provides digital coaching, educational curriculum, and physiological data tools designed for healthcare professionals. The platform delivers on-demand performance coaching and video-based training from experts to support high-stress medical work.

2 investors

Arey develops a clinical anti-aging haircare system designed to reduce grey hair progression through proprietary supplements and topical formulas. The brand targets consumers seeking science-backed solutions to delay and manage visible hair greying.

2 investors

Aria is a practice automation platform for mental health group practices that automates administrative workflows like eligibility verification, claim processing, credentialing, and reporting to allow clinicians to focus on patient care. The platform addresses capacity constraints by enabling practices to grow without proportionally increasing administrative overhead.

2 investors

ArisGlobal provides software for life sciences research and development, covering drug development, drug safety monitoring, and regulatory compliance. It serves biopharmaceutical companies, CROs, and government health authorities, working with over 220 global life sciences organizations.

2 investors

Ark Biosciences is a biopharmaceutical company developing small molecule drugs for infectious diseases, respiratory conditions, neuropsychiatric disorders, and rare diseases. The company has multiple drug candidates in clinical development, with products licensed from partners including Roche and others.

2 investors

Arkangel connects medical science and artificial intelligence to help healthcare teams make faster clinical decisions and reduce documentation errors. The company builds tools for early risk identification and provides evidence-based medical information to support clinical care delivery.

2 investors

Arkos Health partners with payers to transform provider networks and transition to value-based care models. The company helps payers and providers shift from traditional fee-for-service healthcare to value-based arrangements.

2 investors

ArkVax develops glycoconjugate vaccines for animal health using genetic engineering of bacterial cells, aiming to provide broader protection than current vaccines. Its technology targets antibacterial and zoonotic diseases to help combat antimicrobial resistance in both livestock and humans.

2 investors

Arlo partners with and acquires physiotherapy clinics across Canada, handling operational functions such as recruiting, HR, marketing, finance, payroll, technology, and training so clinicians can focus on patient care. It operates as a management and acquisition platform building a network of physio clinics.

2 investors

Aro Biotherapeutics develops tissue-targeted genetic medicines using a proprietary protein technology called Centyrins. The company builds a wholly-owned pipeline of Centyrin-based therapeutic candidates and partners with industry to enable tissue-specific targeting of therapeutics across a range of diseases.

2 investors

Arontier is a company that applies artificial intelligence to drug discovery, using proprietary technology and data to develop treatments for incurable and rare diseases. Founded in 2017, it collaborates with companies, experts, and scholars on new medicines and genetic editing.

2 investors

Arosa provides in-home caregiving, nursing, and care management services to adults requiring support with activities of daily living and chronic disease management. The company operates across multiple U.S. regions and employs nurses, social workers, and care coordinators.

2 investors

Artica Therapeutics develops orally bioavailable small molecule inhibitors that use covalent chemistry to achieve antibody-like efficacy, positioned as an "antibody-in-a-pill" approach. The company targets severe autoimmune and inflammatory disorders for patients with immune-mediated conditions.

2 investors